Single priming and a booster dose of 10-valent and 13-valent pneumococcal conjugate vaccine (PCV) maintains suppression of vaccine serotype colonization in South African children at 3, 4, and 5 years of age: a single-centre, open-labelled, randomized trial

Single priming and a booster dose of 10-valent and 13-valent pneumococcal conjugate vaccine (PCV) maintains suppression of vaccine serotype colonization in South African children at 3, 4, and 5 years of age: a single-centre, open-labelled, randomized trial

Background Surveillance on nasopharyngeal Streptococcus pneumoniae carriage in older children would be informative in determining whether a single priming and booster dose of pneumococcal conjugate vaccine (PCV) provides durable protection against pneumococcal disease compared with traditional dosin...

Full description

Saved in:
Bibliographic Details
Main Authors: Courtney P. Olwagen, Alane Izu, Lara Van der Merwe, Lisa Jose, Anthonet Koen, Shabir A. Madhi
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Expert Review of Vaccines
Subjects:
PCV10
PCV13
durable protection
Streptococcus pneumoniae
nasopharyngeal colonization
Online Access:https://www.tandfonline.com/doi/10.1080/14760584.2024.2417856
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.tandfonline.com/doi/10.1080/14760584.2024.2417856

Similar Items